Indications
Fezolinetant tablet is used to treat moderate to severe vasomotor symptoms that come with menopause.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Fezolinetant is a neurokinin 3 (NK3) receptor antagonist. It blocks neurokinin B (NKB) from binding on the kisspeptin/neurokinin B/dynorphin (KNDy) neuron, and this changes the activity of neurons in the thermoregulatory center. Fezolinetant binds strongly to the NK3 receptor (Ki value of 19.9 to 22.1 nmol/L), and this affinity is more than 450-fold higher than its binding to NK1 or NK2 receptors.
In menopausal women, treatment with fezolinetant did not show any clear trends in the sex hormones that were measured (follicle-stimulating hormone, testosterone, estrogen, and dehydroepiandrosterone sulfate). A transient decrease in luteinizing hormone (LH) levels was seen at the peak concentrations of fezolinetant.
Pregnancy & Breastfeeding
No data exist on the use of Fezolinetant in pregnant women, so it isn't possible to say whether the medicine carries a risk of major birth defects, miscarriage, or other harmful outcomes for the mother or the baby. Nothing is known about breastfeeding either. There are no data on whether fezolinetant passes into human milk, what effect it might have on a breastfed child, or whether it changes milk production.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.